English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
ADC國際化潛力受捧 科倫博泰或享龍頭估值溢價
Jul 20, 2023 20:12 HKT
莱盟健康LAMH董事长兼CEO张泽跃上榜《财富》「40位40岁以下的商界精英」榜单
Jul 19, 2023 18:21 HKT
萊盟健康LAMH董事長兼CEO張澤躍上榜《財富》「40位40歲以下的商界精英」榜單
Jul 19, 2023 18:20 HKT
DC Healthcare Debuts on ACE Market with a Premium of RM0.15 over IPO Price
Jul 17, 2023 11:00 HKT
One More IPO of Legend Capital: Medical Device Supply Chain Service Provider GKHT Medical Goes Public Successfully
Jul 14, 2023 16:17 HKT
Veteran Healthcare Communicator Lea Sims Appointed to Lead CGFNS Marketing and Communications
Jul 11, 2023 19:23 HKT
Veteran Healthcare Communicator Lea Sims Appointed to Lead CGFNS Marketing and Communications
Jul 11, 2023 19:00 HKT
科伦博泰登陆港交所:抢跑ADC赛道 核心产品商业化潜力突出
Jul 11, 2023 15:20 HKT
科倫博泰登陸港交所:搶跑ADC賽道 核心產品商業化潛力突出
Jul 11, 2023 15:19 HKT
Avantor Inaugurates Expanded Singapore Hub
Jul 11, 2023 13:00 HKT
Q&M Free Dental Clinic launched to provide free essential dental treatments for underprivileged individuals and families
Jul 10, 2023 23:00 HKT
科伦博泰即将上市:核心产品研发进度全球领先 市场广阔长期投资价值凸显
Jul 10, 2023 15:06 HKT
科倫博泰即將上市:核心產品研發進度全球領先 市場廣闊長期投資價值凸顯
Jul 10, 2023 15:05 HKT
沛嘉医疗神经介入产品DCwire(TM)微导丝注册申请获药监局批准
Jul 07, 2023 16:00 HKT
沛嘉醫療神經介入產品DCwire(TM)微導絲註冊申請獲藥監局批准
Jul 07, 2023 15:59 HKT
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
Jul 05, 2023 19:00 HKT
四环医药(0460.HK)旗下惠升生物研发的司美格鲁肽注射液获批开展临床实验
Jul 05, 2023 09:51 HKT
四環醫藥(0460.HK)旗下惠升生物研發的司美格魯肽注射液獲批開展臨床實驗
Jul 05, 2023 09:50 HKT
Sihuan Pharmaceutical (0460.HK): Huisheng Biopharmaceutical's Drug Semaglutide Injection Obtained Approval For Clinical Trial
Jul 05, 2023 09:49 HKT
Cure Brain Cancer Foundation Unveils Fellowship Awardees
Jun 30, 2023 14:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: